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Ethnopharmacological research aims at gathering information on local and traditional uses of 
plants and other natural substances. However, the approaches used and the methods 
employed vary, and while such a variability is desirable in terms of scientific diversity, 
research must adhere to well defined quality standards and reproducible methods 
OBJECTIVES 
With ConSEFS (the Consensus Statement on Ethnopharmacological Field Studies) we want 
to define best-practice in developing, conducting and reporting field studies focusing on local 
and traditional uses of medicinal and food plants, including studies using a historical 
approach.  
METHODS 
After first developing an initial draft the core group invited community-wide feedback from 
researchers both through a web-based consultation and a series of workshops at conferences 
during 2017.  
OUTCOMES 
The consultation resulted in a large number of responses. Feedback was received via a 
weblink on the Journal of Ethnopharmacology’s website (ca. 100 responses), other oral and 
written responses (ca. 50) and discussions with stakeholders at four conferences. The main 
outcome is a checklist, covering best practice for designing, implementing and recording 
ethnopharmacological field studies and historical studies.  
CONCLUSIONS 
Prior to starting ethnopharmacological field research, it is essential that the authors are fully 
aware of the best practice in the field. For the first time in the field of ethnopharmacology a 
community-wide document defines guidelines for best practice on how to conduct and report 
such studies. It will need to be updated and further developed. While the feedback has been 
based on responses by many experienced researchers, there is a need to test it in practice by 







Keywords: Traditional medicine, ethnopharmacological field studies, historical studies, 
Consort (adaption), medicinal plants. 
 
 
A large number of reports on peoples’ local and traditional uses of plants as medicines and 
(health) foods are now published every year. The intention very often is to document such 
information and to make it accessible for future research most commonly in drug discovery 
(see Table 1 for references). The scientific goals of research on peoples’ uses of plants differ 
widely. Even before the creation of the term ‘ethnobotany’ in 1896, a large number of studies 
looked at the use of plants, for example as a part of the North American expansion westwards 
(see the analysis of these sources by D. Moerman, 1998) and as pointed out throughout this 
paper, this is in general recording knowledge and not practice. 
In the context of much wider sociocultural studies or botanical explorations and research, 
such plant uses were documented and studied. The term “ethnopharmacology” was first 
coined in 1967 (Efron et al., 1970). A symposium entitled ‘Ethnopharmacologic search for 
psychoactive drugs’ gave the name to a discipline which today is much more broadly defined, 
dealing with local and traditional medicines, their biological activities and chemistry. 
Globalisation has resulted in a world-wide commodification of many traditional medicines 
and psycho-actives, and today it is a flourishing field driven by a wide range of research 
interests (Heinrich and Jaeger, 2015). An essential basis for laboratory-based studies are 
field-studies, i.e. studies documenting and investigating the local and traditional use of 
medicinal and food plants (and other preparations) on all continents. Such field studies 
generally claim – in a broad sense – to contribute to a more evidence based use of such 
resources or to their documentation for posterity (Heinrich et al., 2009).  
One problem which has ‘haunted’ ethnopharmacology is the lack of clearly defined standards 
on how to conduct and report ethnopharmacological field studies c.f. Cotton, 1996; 
Cunningham, 2001; Elizabetsky, 1991; Heinrich et al. 1998; Lipp, 1989; Martin, 1998 or the 
"recommended standards for conducting and reporting ethnopharmacological field studies by 
Weckerle et al.,2017 (which provides guidelines specifically tailored to the J. 
Ethnopharmacol. ) and others. A considerable share of the manuscripts containing original 
data collected in field studies that are submitted to journals have no clear research question, 
hypothesis or objectives. In many of these cases the methods used in the field study are 
inadequate for attaining the research goal or there is a lack of compliance with ethical 
requirements and existing biodiversity regulations. Very often analysis are conducted that 
produce data which is at best doubtful and often non-existent. To give a simple example, 
discussing how many species are used based on the  level of botanical families is not 
meaningful if it is not properly contextualised. From the perspective of the culture (the emic 
perspective), botanical families are not relevant. From a botanical perspective (one of many 
etic ones) it will only be relevant if such data could be compared to the total number of 
species in the region. This would allow the identification of commonly or rarely used 
families. From a pharmaceutical or chemical perspective, there is no need to know this and 
one would not be able to use it in research based on such a field study. One could cite other 
examples of ambiguous or poorly relevant aspects of such reports, but this example must 
suffice. This ambiguity regarding appropriate approaches and methods and how to analyse 
data has resulted in a lack of clear and well-communicated outcomes. The focus of this 
consensus document is about best practice and how to achieve it.  
With this approach we want to develop a well-defined, community-wide consensus on what 
constitutes meaningful objectives and aims of ethnopharmacological field studies and how to 
achieve this. This community-wide consensus defines best practice for developing, 
conducting and reporting ethnopharmacological field studies. While it cannot define 
specifics of a project, it will help all researchers to ascertain that the data are reported in a 
transparent way, that they are meaningful and can be applied in future research (and 
development).  
Written evidence from the past continues to be an important topic in ethnopharmacology. 
Either evidence from the past is compared with modern uses, or research is entirely based on 
historical sources focusing on occurrences or changes in the ethnoflora or its uses over a 
certain period of time (Lardos, 2015). Therefore, the perspective of the consensus document 
has been expanded to include ethnopharmacological studies with a historical approach. These 
can make use of a wide range of resources including historical manuscripts, any kind of 
ethnographic literature or information on plant use preserved in herbarium collections (all of 




Table 1 Selection of topics treated in previous examples of papers covering best practise, in 
methods manuals, specific approaches and international standards 
Topics covered Field of research References 
Best practice on the basis 
of a researcher’s personal 




E.g. Browner et al., 1988; Cotton, 
1996; Cunningham, 2001; 
Elizabetsky 1991; Lipp, 1989; 
Martin, 1995; Weckerle et al., 2017 
Field-specific methods 
manuals 
Cultural anthropology E.g. Bernard (1988; 2000a,b) 
Botany, especially 
herbaria 
E.g. Bridson and Forman (1992) 
Specific approaches or 
steps to be considered 
from the perspective of 




E.g. Browner et al., 1988; Etkin, 
1993; Johnson, 1992. 
Ethnopharmacology, 
especially drug discovery 
E.g. Andrade-Cetto and Heinrich, 
2011. 
Associated ethical and 
biodiversity standards 




E.g. CBD 2001 and 2011; AAA 
2012 as well as previous versions 
and updates; Cragg et al., 1997, 
international laws and 









It has been argued that, instead of studies on the knowledge about traditional medicines, more 
focus needs to be put on understanding the outcomes of such treatments, e.g. retrospective 
treatment outcome studies (Graz et al. 2007). In such studies it is essential that authors 
specify how a plant use is associated with a reported health outcome for a definite ailment in 
order to produce indices of safety and effectiveness. (cf. online tutorial: 
https://globalhealthtrainingcentre.tghn.org/elearning/the-retrospective-treatment-outcome-
study/). While we recognise the importance of the above research, the focus in this consensus 
document is not on treatment outcomes, but on the investigation of local and traditional 
knowledge about medical substances and their use.  
With this document we follow the basic idea of a CONSORT statement, which is an 
evidence-based set of recommendations for best practice in reporting randomized clinical 
trials (www.consort-statement.org/). In medicine efforts to improve the reporting of 
randomised controlled trials dates back to the mid-1990s (Begg et al., 1996; for the most 
recent version see Schulz et al. 2010). These initiatives have been driven by concern about 
the quality, reproducibility and ultimately the usefulness of clinical studies, and the need to 
synthesise their results in systematic reviews and meta-analyses. The guidelines have been 
modified and adapted for a wide range of studies related to the use of treatments, including 
clinical trials of herbal medicines (Gagnier et al. 2005). CONSORT has become an important 
tool to overcome poor reporting of trials. The CONSORT statement offers a standard way for 
authors to report the findings of randomised controlled trials, aiding their critical appraisal, 
interpretation and meta-analysis. 
Here we propose a similar strategy for reporting studies on local and traditional uses of plants 
and other natural substances both in current cultures and in studies using historical 
documentary evidence, which is intended for ethnopharmacological field studies irrespective 
in which journal they are published.  
 
OBJECTIVES 
Ethnopharmacological fieldwork is different from clinical studies, but it is also focused on 
understanding the medical use of substances. In a very general sense, it centres around 
humans’ strategies to overcome illnesses and on the identification of substances used 
therapeutically. With the Consensus Statement on Ethnopharmacological Field Studies 
(ConSEFS), we offer a guideline defining best practice for those studies investigating local 
and traditional medicinal substances (esp. medicinal plants and fungi) aiming at documenting 
this knowledge, contributing to better healthcare at a community level or/ and to identifying 
plants for future developments into medicines or botanicals (supplements, nutraceuticals, 
cosmetics and the like).  
  
THE PROCESS (‘METHODS’) 
During 2016 the core group (the main authors of this paper) developed a first draft of the 
consensus statement. From November 2016 until May 2017, the draft document was open for 
consultation via the website (https://www.journals.elsevier.com/journal-of-
ethnopharmacology/) of the Journal of Ethnopharmacology. The information about it was 
distributed via a range of social media (like via blogs of forntiersin.org), networks of 
academics/ learned societies and through the personal networks of the core group.  
It was discussed and refined at a series of user group meetings at international conferences 
covering key areas relevant in ethnopharmacology during the year 2017: 
- The Int. Soc. Ethnopharmacology mtg. in Beirut, Lebanon (24. – 27.04.; 
www.ethnopharmacology.org and http://webapp.usek.edu.lb/forms/WS/ise/) 
- The Society for Economic Botany meeting in Bragança, Portugal (05. – 09.06.) 
- The Soc. for Ethnopharmacology meeting in Surat, Gujarat, India (22. – 25.02.; 
http://www.ethnopharmacology.in/files/4th_SFEC_2017_Brochure.pdf) 
- The World Congress of Integrative Medicine in Berlin, Germany (03. – 05. 05. 
https://www.ecim-iccmr.org/2017/)  
A group of colleagues was invited to discuss the document within their respective networks 
in Africa, the Americas and Asia and to send their feedback. Feedback was recorded and was 
– after discussions among the core group – included in the final document. Members of the 
core group also met at these meetings (and others). This advisory group and the core group 
then agreed on the final version as published in this paper (Tables 2a and 2b).  
 
RESULTS AND DISCUSSION 
Core recommendations  
The core recommendations as outlined in this document including Tables 2a and 2b, which 
serve as a checklist for assessing a study, focus on the conducting and reporting of 
ethnopharmacological field studies and studies with a historical approach. The two parts of 
the table are designed in such a way that it can be used as a guide covering all steps from the 
initial design to the reporting of an ethnopharmacological field study. 
The specific situations in a country or culture will always differ and the document will need 
to be adapted to these needs generally. These tables cover this through defining best practice 
in all areas relevant in an ethnopharmacological field study and can be used as a checklist, 
which should help researchers, editors, and reviewers to assess a study both during the 
development of the project and during publication. Here we do not wish to repeat these 
recommendations of the table, but to flag important elements.  
It is a guide to facilitate best practice and, of course, is not intended to add another barrier to 
developing, implementing and reporting such studies. Very often many if not all 
recommendations of the statement are largely covered, but far too often manuscripts received 
by learned journals fall far short of these standards (and are often not published), calling for 
such guidelines for best practice. 
Of course, national and international laws and agreements including the Convention on 
Biological Diversity (CBD) and subsequent agreements must be complied with fully. In the 
consultation process the importance of complying with these laws and regulations has been 
stressed frequently, and there is a general consensus that this is an essential prerequisite for 
any ethnopharmacological field study. For each study this must be assessed individually, 
since the international treaties have been translated into individual laws and regulations at 
national level and, of course, these must be followed. The obligations of these treatise focus 
on access, benefit sharing and ascertaining compliance with the regulations.  Since the 
international treaties have been translated into individual laws and regulations at national 
level, the requirements concerning the compliance with existing regulations must be assessed 
individually for each study prior to the start of the field work and in respect of the country of 
research as well as the researcher’s legal domicile (for the purpose of the research). For the 
example of the Nagoya Protocol of the CBD, the appropriate platform for access to this kind 
of information is the Access and Benefit-sharing Clearing-house (ABSCH) which has been 
developed for exchanging information on access and benefit sharing and for facilitating the 
implementation of the protocol (https://absch.cbd.int/). 
During the consultation numerous colleagues highlighted the risk of unsustainable use and 
associated threats to the conservation of resources as exemplified in the following: ‘If natural 
resources used in local medical systems is the subject being dealt with, it is necessary to 
make an effort, where possible, to pay attention to the state of conservation of the species in 
question; species are often brought to the notice of the market through scientific publications, 
and this may indirectly contribute to the risk of over exploitation. I therefore suggest that this 
aspect be described in reports, so that sustainable use is promoted. Even if the work does not 
deal specifically with any of these aspects, I consider that a truly multidisciplinary approach 
like ethnopharmacology should contain information (even if brief) on the conservation status 
of the resources in question, for one reason alone: all the relationships and practices 
associated with the animals and plants used for medicinal and/or alimentary purposes, which 
we study and value so much, depend directly on the availability, access and renewal of these 
resources’ (Ana Ladio pers. Comm. 17.01.17). 
This is included in several parts of the checklist (esp. Table 2a) and an essential basis for this 
is that researchers build up a detailed understanding of the specific situation in a certain 
region or country.  
 
An important requirement and an overarching requirement is the need for well-described 
primary data – these must be reported in the manuscript or an appendix. Journal requirements 
on the content will vary. For example, some journals will prefer reports on specific disease 
groups while others expect a more monographic treatment of a region.  
 
Introduction 
The relevant conceptual and theoretical basis of the paper must be included and it must be 
embedded in the respective literature. An important part is a section providing the 
ethnographic and geographical background to the study.  
 
The methods must be described clearly and must cover all aspects from design (including 
permits and approvals) to the execution of the field study and to the way the data were 
analysed. These methods are equally relevant if they are used in community-based research, 
where direct interviews or surveys are conducted, as they are in studies using web-based 
methods and strategies (currently much less common in ethnopharmacology). 
As indicated in Table 2a, primary data need to report the frequency of use, or knowledge 
about a species or similar quantitative data. Usually primary data is presented in the form of 
frequency of use-reports (individual citations) of a plant taxon or organs/ parts thereof for a 
specific use or a category of use including the mode of application and the product’s 
preparation. Often, percentage values can reasonably be used for comparisons. 
Indices are commonly used for transforming primary data, but need to be meaningful, 
provide additional insights and be statistically correct. Major concerns have been raised about 
their usefulness, relevance and robustness (e.g. Weckerle et al. 2017; Dudney et al. 2015). 
Here we do not endorse any specific indices.  
  
Results and discussion 
(as a combined or separate sections) should focus on what the core novel findings are and 
how they are linked to the previous knowledge. Many of the data will generally be reported 
in a quantitative or semi-quantitative way and this may again be influenced by a specific 
journal’s editorial policy. Explicitly, we want to encourage researchers to report and discuss 
problems encountered during the research, and how they were overcome. The data need to be 
compared to previous research on the topic. This can be other studies in the same region, with 
the same linguistic family, in a similar ecological or political context or studies which used a 
similar approach. Authors should discuss priorities for future research steps and what new 
challenges this research is pointing to. 
 
Conclusions 
Should critically assess the implications of the study and its findings, and highlight future 
research needs. 
 
The majority of the points relevant for field studies are also, at least to a certain extent, of 
direct relevance for studies relying on documented evidence from the past (see Table 2a, 
column “Relevant for historical studies”). There are, of course, certain points, which are 
specific for historical studies, and these are detailed in Table 2b. Of particular importance in 
this context are the description of the resource and how it was accessed, the method used to 
extract the relevant ethnopharmacological information, the identification of the plants or 
other natural products and the interpretation of the (medicinal) uses mentioned in it. 
 
Limitations 
Importantly, the focus here is on ethnopharmacological field studies or historical studies 
which address questions on the use of medicinal and (health) food plants, if it is the goal of 
the authors to document such local and traditional medical knowledge, to contribute to better 
healthcare at a community level or/ and to identify plants for future developments into 
medicines or botanicals (like supplements, nutraceuticals, cosmetics). Of course, it cannot be 
all-inclusive. For example, it is not intended for other studies in the ethnosciences, like 
cognitive or ethnolinguistic research.  
While research is by definition focusing on some aspects of a culture, medical practice in a 
culture is always a part of a complex and integrated network of knowledge and practice. We 
recognise that local and traditional knowledge cannot be represented in an integrated and all-
encompassing way. However, in the studies we focus on here, such an integrated perspective 
is generally neither the goal nor would it be realistic to expect it.  
Again, concerns about the environmental context were a common theme in the consultation 
and were highlighted by participants in the four workshops at the conferences and in 
numerous responses by researchers.  
 
IMPLICATIONS AND CONCLUSIONS 
Foremost, ConSEFS is intended to help researchers to develop and report research on the use 
of local and traditional medicines. Planning for the final outcomes of a research project, most 
commonly a publication, starts when developing a research question and the project itself. 
Prior to starting ethnopharmacological field research, it is essential that the authors are fully 
aware of the best practice in the field including the guidelines in this paper. We trust that 
these guidelines will also be accepted by the relevant journals where ethnopharmacological 
field studies are published and that they are used in the evaluation of manuscripts.  
In the consultations concerns were raised that it is an additional bureaucratic barrier, but 
clearly it is not. It simply defines the current best practice in this field of research. Similarly, 
it provides editors and peer reviewers with a tool to review manuscripts prior to publication, 
and helping readers in understanding best practice in published articles reporting such 
studies.  
This paper does not provide a ready-made recipe for conducting and reporting research (but 
see Collins et al. (2017)) and instead highlights how to avoid potential pitfalls and how to 
achieve the scientific goals of ethnopharmacological research. It is a next step in an ongoing 
debate and development and will help in further improving best practice in research.  
 
Acknowledgements 
We are very grateful to the many colleagues who have sent us feedback, on all aspects of this 
statement. While we will not have done justice to all, nor has it been possible to incorporate 
the often contradictory views, the consensus statement and this article have greatly benefitted 
from everyone’s input. We are grateful to all who helped to disseminate the information 
about earlier drafts of this document, most importantly Anne Marie Pordon (Elsevier) and 
Brian Boyle (Frontiers) and well as to the many colleagues who disseminated the information 
in their networks. 
This project received no external funding. 
 
Authors’ contributions 
MH. designed the overall strategy for the consensus process and the manuscript. In 
consultation with the other authors (AL, ML, CW, MW) he drafted the initial version of the 
best practice checklist (now included as Table 2a and b in the paper). The advisory group 
facilitated discussions in specific regions and provided feedback on various aspects of this 
checklist as well as commented on earlier drafts of the MS.  
 
References 
AAA (American Anthropological Association), 2012. Statement on Ethics. Principles of 
Professional Responsibility. First approved 1971, as amended, 
http://ethics.americananthro.org/category/statement/ (last accessed 10.05.2017). 
Andrade-Cetto, A., Heinrich, M., 2011. From the field into the lab: Useful approaches to 
selecting species based on local knowledge. Fr. Pharmacol. (Ethnopharmacol.) 2, 20. doi: 
10.3389/fphar.2011.00020 
Begg, C., Cho, M., Eastwood, S., Horton, R., Moher, D., Olkin, I., et al., 1996. Improving the 
quality of reporting of randomized clinical trials: the CONSORT statement. JAMA 276: 
637-339. 
Bernard, H.R., 1988. Research Methods in Cultural Anthropology. Sage Publ., New York, 
USA. 
Bernard, H.R., 2000a. Social Research Methods, Qualitative and Quantitative Approaches. 
Sage Publications, Thousand Oaks. 
Bernard, H.R., 2000b. Handbook of Methods in Cultural Anthropology. Alta Mira Press, 
Walnut Creek, Lanham, New York, USA and Oxford, UK. 
Bernard, H.R., 2011. Research Methods in Anthropology – Qualitative and Quantitative 
Approaches, 3
rd
 edition, Altamira Press, New York, USA. 
Bridson, D., Forman, L., 1992. The Herbarium Handbook. Revised ed. (first publ. in 1989)], 
Kew, Royal Botanic Gardens, Richmond, UK.  
Browner, C.H., Ortiz de Montellano, B.R., Rubel, A.J., 1988. A methodology for cross-
cultural ethnomedicinal research. Curr. Anthr. 29:681-702. 
CBD, 2001. Handbook of the Convention on Biological Diversity. Secretariat of the 
Convention on Biological Diversity. Earthscan Publ., London. 
CBD, 2011. Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable 
Sharing of Benefits Arising from their Utilization to the Convention on Biological 
Diversity. Convention on Biological Diversity. United Nations, Montreal, Canada.  
CITES: https://cites.org/eng/app/appendices.php (accessed 20.06.2017) 
Collins, S., Gemayel, R., Chenette, E.J., 2017. Avoiding common pitfalls of manuscript and 
figure preparation. FEBS J. 284, 1262–1266. 
CONSORT: www.consort-statement.org/ (accessed: 20.06.2017) 
Cotton, C.M., 1996. Ethnobotany: Principles and Applications. Wiley and Sons, Chichester. 
UK.  
Cragg, G.M., et al., 1997. Interactions with Source Countries. Guidelines for Members of the 
American Society of Pharmacognosy. J. Nat. Prod. 60, 654-655. 
Cunningham, A.B., 2001, Applied Ethnobotany: People, Wild Plant Use and Conservation, 
(People and Plants Conservation Manual) Earthscan Publications Ltd. London, UK and 
Sterling, VA, USA. 
Dauncey, E.A.; Irving, J., Allkin, R., Robinson, N., 2016. Common mistakes when using 
plant names and how to avoid them. Eur. J. Integrat. Med. 8, 597–601. 
Descola, P., 2005. Par-delà nature et culture. Gallimard, Paris. 
Dudney, K., Warren, S., Sills, E., Jacka, J., 2015. How study design influences the ranking of 
medicinal plant importance: a case study from Ghana, West Africa. Econ. Bot. 69, 306–317. 
Edwards, S., Nebel, S., Heinrich, M., 2005. Methodological and epidemistiological 
considerations on the use of questionaires in ethnopharmacology. J. Ethnopharmacol. 100, 
30–36.  
Efron, D., Farber, S.M., Holmstedt, B. et al., 1970. Ethnopharmacologic search for 
psychoactive drugs. Reprint, orig. 1967. Public Health Service Publications no. 1645. 
Government Printing Office, Washington, DC.  
Elisabetsky, E., 1991. Sociopolitical, economical, and ethical issues in medicinal plant 
research. J. Ethnopharmacol. 32, 235–239. 
Ember, C.R., Ember, M., 2001. Cross-Cultural Research Methods, AltaMira Press, Lanham, 
MD. 
Etkin, N.L., 1993. Anthropological methods in ethnopharmacology. J. Ethnopharmacol. 38, 
93–104. 
Gagnier, J.J., Boon, H., Rochon, P., Moher, D., Barnes, J., Bombardier, C.(for the 
CONSORT Group), 2005. Reporting Randomized, Controlled Trials of Herbal 
Interventions: An Elaborated CONSORT Statement. Ann. Int Med. 144, 363–367 
Global Health Training Centre: https://globalhealthtrainingcentre.tghn.org/elearning/the-
retrospective-treatment-outcome-study/ (accessed: 20.06.2017) 
Graz, B., Elisabetsky, E., Falquet, J., 2007. Beyond the myth of expensive clinical study: 
Assessment of traditional medicines. J. Ethnopharmacol.113, 382–386.  
Heinrich, M., Jaeger, A.K. (Eds.), 2015. Ethnopharmacology. Wiley, Chichester.  
Heinrich, M., Ankli, A., Frei, B., Weimann, C., Sticher, O., 1998. Medicinal plants in 
Mexico: healers’ consensus and culturalmportance. Soc. Sc. Med. 47, 1863–1875. 
Heinrich, M., Edwards, S., Moerman, D.E., Leonti, M., 2009. Ethnopharmacological Field 
Studies: A Critical Assessment of their Conceptual Basis and Methods. J. Ethnopharmacol. 
124, 1–17.  
Johnson, M. (Ed.), 1992. LORE, Capturing Traditional Environmental Knowledge. Dene 
Cultural Institute and IDRC, Ottawa. 
Lardos, A., 2015. Historical Approaches in Ethnopharmacology. In: Heinrich, M. and A.K. 
Jaeger (Eds.), Ethnopharmacology. Wiley, Chichester.  
Lipp, F.J., 1989. Methods for ethnopharmacological fieldwork. J. Ethnopharmacol. 25:139-
150. 
Martin, G.M., 1995. Ethnobotany. Chapman and Hall, London, UK (on a little island off the 
coast of Eurasia). 
Medicinal Plant Names Services. Kew, Royal Botanical Gardens. http://mpns.kew.org/mpns-
portal/ (accessed 20.06.2017) 
Moerman, D. E., 1998. Native American Ethnobotany. Timber Press, Portland, OR, USA. 
Ortiz de Montellano, B., 1975. Empirical Aztec medicine. Science 188, 215–220. 
Rivera, D., Allkin, R., Obón, C., Alcaraz, F., Verpoorte, R., Heinrich, M., 2014. What is in a 
name? The need for accurate scientific nomenclature for plants. J. Ethnopharmacol. 152, 
393–402. 
Schulz, K.F., Altman, D.G., Moher, D. (for the CONSORT Group), 2010. CONSORT 2010 
statement: updated guidelines for reporting parallel group randomised trials. Br. Med. J. 
340: c332 
Soejarto, D.D., Fong, H.H.S., Tan, G.T., et al., 2005. Ethnobotany/ethnopharmacology and 
mass bioprospecting, issues on intellectual property and benefit-sharing. J. 
Ethnopharmacol. 100, 15–22. 
The ISE Code of Ethics: http://www.ethnobiology.net/what-we-do/core-programs/ise-ethics-
program/code-of-ethics/ (accessed 20.06.2017) 
The Plant List: http://www.theplantlist.org/ (accessed 20.06.2017) 
Weckerle et al., 2017 Recommended standards for conducting and reporting 





Table 2a: Best practice in ethnopharmacological field studies in the context 
of research on bioactive natural products  
Section, Item 
(this will vary 























best reporting for 
each of these 
points)  
Notes 












Title Title N/A Clear definition or 
headline outcomes 
of the overall 





















An overview of the 
main findings must 






Overview on rationale for the study, and 
clearly defined objectives for this study (or a 












state of the 



















within the whole 





















Clear description of 
the conceptual basis 













be tested?  
rationale. Define 
the gap of 
knowledge this 






Review of the 
literature 
relevant to 




previous studies in 
the region of study, 
or in linguistically 
or otherwise related 
groups and / or of 
studies which 
















Specific and clearly 
defined aims and 
objectives/hypothes
is to be tested. 
While a study may 




only provide the 
baseline data of 
such a paper and 
cannot be a sole 












Short review of the 
area and relevant 






























(possibly in tabular 
form) or at least 
references to these. 
What kind of health 
care choices and 
facilities are 
available to the 





















look also for 
Summarise 
previous studies 





























period, duration of 
fieldwork, number 
of fieldworkers, 
their expertise (i.e. 
training, language 
used in the 
interviews) and 
their contribution, 
use of interpreters; 
tools used and how 
they were 
developed.  
For a general 
overview see 




























storage of plants, 
collectors and 
specimen numbers, 
information on the 
taxonomic 
validation of the 
species, repositories 









Dauncey et al 2016; 





































of the survey 
methods used (e.g. 
through piloting); 
recruitment strategy 




locations where the 
data were collected 
(incl. use of 
translators). If 
applicable, 
selection of a 
comparator group 





















sample size and 
how participants 


















background of each 
participant (proof of 
consent for 
publishing this data 








doctor in the 
design and 
development 












with use of 
the plants.  
Criteria used to 
define the uses 
reported or 
observed and how 
these criteria were 
defined (e.g. based 
on participant’s 
statements, medical 












































patients), and if 
applicable, how the 
diseases or 
condition was 
diagnosed about the 
validation of any 
clinical tools used 
and of the 








version), esp. the 
one for herbal 
medicines needs to 













Types of interviews 
and other tools used 
for data collection 
should be specified. 
If applicable, copy 
of the questionnaire 






In general terms, all 
information 
 Yes 















to be included. 
Strategy and 
statistics, tools used 




analysis of the data  
Additiona



















description how the 
data were analysed 




















botanical and social 
science standards 
and agreements / 
protocols, approval 
by an institutional 
or national review 





for research and 



































protocols (i.e the 
CBD, subsequent 
agreements,  most 








on any agreement 
on access and 
benefit-sharing, 
compliance with the 
relevant agreements 
and whether the 







For example, in the 
European Union this 
is implemented 
through Regulation 
(EU) No. 511/2014 in 
order to assure 

















In general journals 
will expect a 
substantial set of 
data, small samples 










may be on an 
entire 
medicinal 
flora of a 
region or on 
materia 








al 2017).  
Descriptive 
(ethnographic
















numbers of species 




Often a journal will 
expect the coverage 
of the entire 
medicinal flora 
(materia medica) of 
a region or, for 
example, of a 
specific therapeutic 
category. . This 
needs to be defined 
on the basis of a 
journal’s specific 
guide to authors. 
The triangulation of 
the data gathered is 
essential. 





Main data See previous 
point 
There needs to be a 
focus on what were 
the main outcomes 
of the study based 
















A table (or more) 




scientific name of 
the plant, the plant 
part used, the 
method of 
preparation, the 
dosage, route of 
administration, 
whether it is 
combined with 
other plants, how 
many participants 
mentioned this 




(i.e. that they 
themselves or their 
patients improved 














fully valid names 





have to be 
excluded due 



























can be used 
to analyse the 
data in a 
meaningful 
way 
Data on medical 
uses need to 




species in the 
region. The 
quantification 






data) of the mode of 
application and use 
of a specific drug, 


















In the design 


















Relevance of the 
study in the context 














An assessment of 
the methodological 
limitations must be 
included. Also 
included must be 
external and 
internal factors, 
which may have 
affected the study. 
Factors and changes 
to the initial study 
protocol, which will 
have affected the 
study. Bias caused 
due to sampling 
strategy or other 
factors.  
 Yes 
A discussion of any 
problems (e.g. lack 
of willingness to 
collaborate) 
encountered during 









N/A Have the research 
questions (as 
outlined in the aims 
and objectives) 











studies as a 















other studies in the 
region or which 
have used similar 
approaches 
An evaluation of 
the existing 
evidence on  the 
most frequently 
cited plants. Are 
these “new” or 





























assessment of how 
this information 
will be of scientific 
relevance  
Implicatio
















Assessment of how 
this study impacts 


















and why?  




which have also 




preclinical / clinical 
studies have been 
done to test their 
safety, 
pharmacological 












assessment of the 
implications of the 
study and its 
findings, including 










N/A Inclusion of 
research tools and 
other materials like 
questionnaire/ 
interview guide 




Funding N/A Financial support 
received. Any 
commercial or other 
interests that need 










The support of all 
involved needs to 
be included (as is 
the standard in 
scientific practice) 
local peoples. If 
images of persons 
are included, in the 
 Yes 
paper, permissions 
need to be obtained 
in advance. 





Table 2b. Additional points referring specifically to historical studies 
(especially to the analysis of historical texts) 
Many of the more general points listed in the above table on the field studies (Table 2a) are 
also applicable for historical studies. 
Section, Item 
(this will vary 







aspects to be 
covered) 
Design (information 
for best practice in 
designing for each of 
these points) 
 Reporting 
(information for best 
reporting for each of 
these points) 
Notes  
Title See Table 
2a 
 





Assessment of the 
context and importance 






texts) and its 
significance as a 



















Review of the literature 
to understand how the 
text is embedded in the 
relevant cultural-
historical environment 
and, if applicable, how 
it is linked to other 
written traditions. 
Short review of the 
cultural and historical 
setting concerned and 
details about the 
relevant indigenous, 
ethnic or cultural 
group. Impact, if any, 
of the text on today’s 








See Table 2a 
 
In case of an unedited 
or non-translated text it 




Details about the 
general procedure used 
to access and analyse 
the text, including 
specific tools used and 
how they were 
developed; 
Contribution and 






the text, access 
and data 
extraction  
Locate the relevant 
copy or edition of the 
text (physical or digital 
archive) and establish 
access to it. 
Develop a protocol for 
analysing the text that 
is specific to your focus 
and research question.  
 
Description of the text 
investigated including 
type, format, language, 
date and place of 
origin and where it is 
stored today; The 
method used to extract 
relevant information 
from the text (e.g. 
manual line by line 
reading or computer 




of plants or 
other natural 
products  
The identification of 
plants or other natural 
substances mentioned 
in the text should 
involve a broadly based 
body of literature (e.g. 
pharmacognostic 
reference texts, 
dictionaries of materia 
medica and other useful 





contained in the text 
can be valuable in this 
context but should be 
used in combination 
with other information 
available; 
Pharmacognostic 
samples of the relevant 
culture or tradition that 
are held in collections 
can contribute to the 
identification 
procedure.  
Plant names cited in 
the text should be 
listed and the 
references used to 
identify them cited for 
each case; Scientific 
names stated in the 
references used need to 
be verified based on 
information in up-to-












the analysis of 






historical texts difficulties in 
accessing the 
resources, legibility of 
original manuscripts, 
uncertainties in the 
plant identifications 
and the interpretations 
of symptoms and 
diseases).  
 







N/A Complete list of the 
plant names mentioned 
in the text and their 
cross-referencing with 
scientific names; If 
applicable, scans of the 
plant illustrations or 
photographs of 
pharmacognostic 
samples involved in 
the identification 
procedure. 
Specifically 
refers to 
unedited 
texts. 
 
 
 
 
 
